Congo vs Costa Rica: Antiretroviral therapy coverage for PMTCT
Congo
42.0%
in 2024
Costa Rica
42.0%
in 2024
Congo rank
70th
Costa Rica rank
70th
Antiretroviral therapy coverage for PMTCT over time
- Congo
- Costa Rica
How they compare
Congo currently reports 42.0% against 42.0% in Costa Rica, a difference of 0.0%.
Across all 22 years both countries report, Costa Rica has been ahead every year.
Congo ranks 70th and Costa Rica ranks 70th of 84 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Congo | Costa Rica | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.2% | 24.5% | 19.3% | Costa Rica |
| 2010s | 14.6% | 81.0% | 66.4% | Costa Rica |
| 2020s | 27.0% | 70.4% | 43.4% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Congo or Costa Rica?
- Congo, at 42.0% against 42.0% in Costa Rica as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Congo and Costa Rica?
- 0.0%, with Congo ahead.
- How many years of comparable data are there for Congo and Costa Rica?
- 22 years are reported by both, from 2000 to 2024.
- How do Congo and Costa Rica rank globally for antiretroviral therapy coverage for pmtct?
- Congo ranks 70th and Costa Rica ranks 70th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).